Multiplexed Immunofluorescence (IF) Analysis and Gene Expression Profiling of Biopsies from Patients with Relapsed/Refractory (R/R) Diffuse Large B Cell Lymphoma (DLBCL) Treated with Lisocabtagene Maraleucel (liso-cel) in Transcend NHL 001 Reveal Patterns of Immune Infiltration Associated with Durable Response
Year: 2019
Type: conference-abstract
Source: Blood
Institution: Juno Therapeutics (United States)
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: relapsed/refractory diffuse large B-cell lymphoma, lisocabtagene maraleucel, CAR T-cell therapy, anti-CD19, 4-1BB, tumor microenvironment, immune cell infiltration, PD-L1, PD-1, EGFR, tumor-infiltrating lymphocytes, regulatory T cells, myeloid-derived suppressor cells, gene expression profiling, durable response
Open Access status: closed
OpenAlex ID: W2990276613
